From technological iteration to clinical breakthrough: advances of CAR-T cell therapy in autoimmune diseases
CAR-T cell therapy represents a revolutionary therapeutic strategy for the management of refractory AIDs. Addressing current challenges will further promote its clinical translation and expand its application in the treatment of AIDs.
Authors
- Jingkai Xu (ORCID: https://orcid.org/0000-0002-3640-1602)
- Yu Bf
- Y C Cui
Institutions
- Chinese Academy of Medical Sciences & Peking Union Medical College (CN)
- China-Japan Friendship Hospital (CN)
- Peking Union Medical College Hospital (CN)
- Knowledge Integration (United Kingdom) (GB)
Publication Details
- Journal
- Annals of Medicine
- Published
- 2026-02-09
- DOI
- https://doi.org/10.1080/07853890.2026.2627057
- Primary Topic
- CAR-T cell therapy research
- Type
- article
- Field-Weighted Citation Impact
- 0.00